Episode 282 - Deep Dive into the Proposed 2027 CMS Payment Rule, Anesthesia Stipends, the NOPAIN Act, a $12M ASC Valuation Lawsuit - July 3, 2026ment Rule - July 3, 2026

In this episode of the ASC Podcast with John Goehle, we cover a money-focused news segment — the anesthesia stipend crisis by the numbers, a refresher on the NOPAIN Act and the separate Medicare payment it created for non-opioid pain management, and a $12 million ASC valuation lawsuit in Iowa. We also share a few things we've been seeing in the field. Then we go all-in on the big one: CMS's just-released proposed payment rule for 2027 — the proposed ASC update, the market-basket question, the Covered Procedures List, the device and NOPAIN provisions, quality-reporting changes, and the site-of-service savings — plus the summary and spreadsheet we built — and a video walkthrough coming to conferences.asc-central.com — to help you assess the impact on your center.

This episode is sponsored by Surgical Information Systems, RFX Solutions, Medserve and Ambulatory Healthcare Strategies.

Notes and Resources from this Episode:

 

INFORMATION ABOUT THE ASC PODCAST WITH JOHN GOEHLE

ASC Central is our one-stop site for ASC bootcamps, on-demand conferences, and membership programs: conferences.asc-central.com

Patron Membership — our base membership for podcast listeners: regular group Zoom sessions, a full resource database to help run your ASC, and several free conferences (Conditions for Coverage, Medical Director, Credentialing, and Finance & Accounting). Become a Patron Member

Premium Access Program — includes Patron membership PLUS unlimited Bootcamps (Administrator and Director of Nursing, normally $1,899.99 each), our Credentialing, Conditions for Coverage, Medical Director and Infection Control programs, weekly drop-in Zoom sessions, and up to five hours of private consulting. Sign up for Premium Access

Compare both programs:


Отзывы


Podcastly – the best platform for podcasters and podcast lovers. More than 10 millions of audio content that available on Android/iOS/Web/Desktop and Telegram.